Aytu Capital Expenditures from 2010 to 2024

AYTU Stock  USD 1.61  0.01  0.62%   
Aytu BioScience Capital Expenditures yearly trend continues to be comparatively stable with very little volatility. Capital Expenditures will likely drop to 0.00 in 2024. From the period from 2010 to 2024, Aytu BioScience Capital Expenditures quarterly data regression had r-value of  0.22 and coefficient of variation of  187.11. View All Fundamentals
 
Capital Expenditures  
First Reported
2006-09-30
Previous Quarter
0.0
Current Value
136 K
Quarterly Volatility
2.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 4.6 M or Selling General Administrative of 12.1 M, as well as many indicators such as Price To Sales Ratio of 304, Dividend Yield of 0.0 or PTB Ratio of 3.34. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
  
Check out the analysis of Aytu BioScience Correlation against competitors.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Latest Aytu BioScience's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Aytu BioScience over the last few years. Capital Expenditures are funds used by Aytu BioScience to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aytu BioScience operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Aytu BioScience's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aytu BioScience's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Pretty Stable
   Capital Expenditures   
       Timeline  

Aytu Capital Expenditures Regression Statistics

Arithmetic Mean886,816
Geometric Mean0.00
Coefficient Of Variation187.11
Mean Deviation1,231,689
Median59,848
Standard Deviation1,659,343
Sample Variance2.8T
Range5.8M
R-Value0.22
Mean Square Error2.8T
R-Squared0.05
Significance0.43
Slope81,031
Total Sum of Squares38.5T

Aytu Capital Expenditures History

20202.3 M
20195.8 M
201859.8 K
201774.7 K
2016111.6 K
20152.3 M
2014252.9 K

About Aytu BioScience Financial Statements

Aytu BioScience shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.